Inhibition of Tryptophan Catabolism Is Associated With Neuroprotection During Zika Virus Infection
暂无分享,去创建一个
R. Dantzer | J. Alves-Filho | C. Queiroz-Junior | T. Cunha | V. Costa | F. Marim | A. Teixeira | Bruno V S Valiate | M. Teixeira | D. C. Teixeira
[1] Zhiheng Xu,et al. Different Gene Networks Are Disturbed by Zika Virus Infection in A Mouse Microcephaly Model , 2020, Genom. Proteom. Bioinform..
[2] Jin Yu,et al. Regulation of indoleamine 2, 3‐dioxygenase in hippocampal microglia by NLRP3 inflammasome in lipopolysaccharide‐induced depressive‐like behaviors , 2020, The European journal of neuroscience.
[3] C. Limatola,et al. Chemokines: Key Molecules that Orchestrate Communication among Neurons, Microglia and Astrocytes to Preserve Brain Function , 2020, Neuroscience.
[4] R. Schinazi,et al. 7-Deaza-7-Fluoro-2'-C-Methyladenosine Inhibits Zika virus Infection and Viral-induced Neuroinflammation. , 2020, Antiviral research.
[5] Richard O. Williams,et al. IDO and Kynurenine Metabolites in Peripheral and CNS Disorders , 2020, Frontiers in Immunology.
[6] J. Klode,et al. Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain , 2020, Frontiers in Immunology.
[7] T. Yeh,et al. Influenza A virus infection induces indoleamine 2,3-dioxygenase (IDO) expression and modulates subsequent inflammatory mediators in nasal epithelial cells , 2019, Acta oto-laryngologica.
[8] pNuha Algarzaep. Zika virus outbreak , 2019 .
[9] L. McCullough,et al. Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence , 2019, Front. Neurol..
[10] Joshua A. Jackman,et al. In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapy , 2019, EBioMedicine.
[11] M. Consolaro,et al. Persistence and clinical relevance of Zika virus in the male genital tract , 2019, Nature Reviews Urology.
[12] Joshua A. Jackman,et al. Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide , 2018, Nature Materials.
[13] G. Prendergast,et al. Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer , 2018, Front. Oncol..
[14] P. Conn,et al. The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease , 2018, Journal of neurochemistry.
[15] E. Rosenberg,et al. Transcriptional Changes during Naturally Acquired Zika Virus Infection Render Dendritic Cells Highly Conducive to Viral Replication. , 2017, Cell reports.
[16] Marion C Lanteri,et al. An update on Zika virus infection , 2017, The Lancet.
[17] K. Engedal,et al. The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance , 2017, Front. Psychol..
[18] M. Teixeira,et al. Zika Virus Promotes Neuronal Cell Death in a Non-Cell Autonomous Manner by Triggering the Release of Neurotoxic Factors , 2017, Front. Immunol..
[19] N. Vasilakis,et al. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond , 2017, Nature Reviews Drug Discovery.
[20] H. Nakaya,et al. N-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus Infection , 2017, mBio.
[21] J. Saiz,et al. The Race To Find Antivirals for Zika Virus , 2017, Antimicrobial Agents and Chemotherapy.
[22] Kuniaki Saito,et al. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences , 2017, Neuropharmacology.
[23] J. Neyts,et al. Zika and Other Emerging Viruses: Aiming at the Right Target , 2016, Cell Host & Microbe.
[24] R. Tesh,et al. Characterization of a Novel Murine Model to Study Zika Virus , 2016, The American journal of tropical medicine and hygiene.
[25] P. Garcez,et al. Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.
[26] Amadou A. Sall,et al. The Brazilian Zika virus strain causes birth defects in experimental models , 2016, Nature.
[27] L. de Noronha,et al. Zika virus damages the human placental barrier and presents marked fetal neurotropism , 2016, Memorias do Instituto Oswaldo Cruz.
[28] Koanhoi Kim,et al. Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses , 2016, Journal of Neuroinflammation.
[29] Graham Hall,et al. A Susceptible Mouse Model for Zika Virus Infection , 2016, bioRxiv.
[30] M. L. Barjas-Castro,et al. First Complete Genome Sequence of Zika Virus (Flaviviridae, Flavivirus) from an Autochthonous Transmission in Brazil , 2016, Genome Announcements.
[31] S. Sardi,et al. Zika Virus Outbreak, Bahia, Brazil , 2015, Emerging infectious diseases.
[32] A. Ferreira,et al. Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats , 2015, PloS one.
[33] Hiroyasu Ito,et al. Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing. , 2015, Biomaterials.
[34] F. Giorgini,et al. The kynurenine pathway and neurodegenerative disease. , 2015, Seminars in cell & developmental biology.
[35] A. Hara,et al. Blockade of Indoleamine 2,3-Dioxygenase Reduces Mortality from Peritonitis and Sepsis in Mice by Regulating Functions of CD11b+ Peritoneal Cells , 2014, Infection and Immunity.
[36] M. Teixeira,et al. Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice , 2014, Medical Microbiology and Immunology.
[37] T. Möller,et al. Kynurenines in CNS disease: regulation by inflammatory cytokines , 2014, Front. Neurosci..
[38] B. Leavitt,et al. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain , 2013, Experimental Neurology.
[39] R. Tripp,et al. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection. , 2013, The Journal of general virology.
[40] B. Brew,et al. The Kynurenine Pathway in Stem Cell Biology , 2013, International journal of tryptophan research : IJTR.
[41] P. Klivényi,et al. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders , 2012, Journal of the Neurological Sciences.
[42] R. Stocker,et al. Flavivirus infection induces indoleamine 2,3‐dioxygenase in human monocyte‐derived macrophages via tumor necrosis factor and NF‐κB , 2012, Journal of leukocyte biology.
[43] E. Kroon,et al. Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice , 2011, Journal of Neuroinflammation.
[44] R. Lanciotti,et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. , 2009, The New England journal of medicine.
[45] Z. Qin,et al. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases , 2009, Acta Pharmacologica Sinica.
[46] Gilles J Guillemin,et al. Characterization of the Kynurenine Pathway in Human Neurons , 2007, The Journal of Neuroscience.
[47] F. Macnamara. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. , 1954, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[48] C. Queiroz-Junior,et al. Zika virus Infection and Potential Mechanisms Implicated in Neuropsychiatric Complications , 2020 .
[49] Per Magne Ueland,et al. Kynurenine Pathway Metabolites in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[50] R. Dantzer,et al. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. , 2009, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[51] Hans-Georg Rammensee,et al. IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism , 2008, Cancer Immunology, Immunotherapy.